ARGX-118

ARGX-118 was designed as a highly differentiated antibody against Galectin-10, the protein of Charcot-Leyden crystals (CLCs), which are implicated as a major contributor to airway inflammation and to the persistence of mucus plugs.

Target
Galectin-10
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Potential in severe airway inflammation indications